Introduction
In recent years, oral supplements marketed as “skin, hair, and nail” supplements are becoming popular and trendy treatments in the world of the skin health1,2. These products are also called “nutricosmetics” and represent the new frontier of the beauty industry3. The concept behind nutricosmetics is related to their ability to work from the inside promoting the beauty from within. This category of “beauty” supplements boosts the Consumer hope to improve the appearance using a capsule, seeking out the “hope in a capsule”. The role of food supplements in correcting/integrating the deficiency of some nutrients, in contributing to to maintaining an adequate intake of certain nutrients and in supporting or improving specific physiological functions is widely recognized by both the regulatory bodies and the scientific community4. However, the evidence is sparse for most supplements1,5.
The role of nutrition support in improving skin health is nowadays evidence6-8. Clinical and epidemiological research have successfully combined nutrition with skin health and aging9. The aging related changes of the skin structures involves the degradation and the alteration of collagen fibers throughout the dermis10. Furthermore, amino acids are the building blocks of the most abundant protein the skin, like keratin, collagen, and elastin. Their role in maintaining skin health was demonstrated for: water retention in the stratum corneum, protection from UV-induced damage, maintenance of the skin microbiome balance, and wound healing10. Glycine, proline, and hydroxyproline (the most abundant amino acids of collagen composition) role in collagen synthesis and animal growth have been reported in different studies11, 12. The present study investigated the efficacy of the oral supplementation of a food-supplement containing Glycine, L-Alanine, L-Proline, L-Valine, L-Leucine, L-Lysine, on skin aging.
Regarding the product effect on hair, our attention was focused on transient hair shedding (i.e. acute telogen effluvium, aTE). aTE is a transient, non-scarring shedding of normal club hair13. Usually aTE undergoes to remission in around of 95% of case, with the evidence on examination of shorter re-growing frontal hair13. Even if hair loss is not a life-threatening condition, it is a common complaint and cause of significant emotional distress especially in women4,14. Like for the skin, amino acids are a major constituent of hair fibers. The role of l-lysine was demonstrated to be effective in decreasing the excessive hair shedding in a female population with a mechanism of action that was probably related to its effect in replenishing iron stores15.
Nail plate brittleness is a common complaint affecting up to 20% of the population. The fragility of the nail plate consist of nails splitting, flaking, and crumbling. Therefore, nails become soft an inelastic16. We decide to focus our attention of the “brittle nail syndrome (BNS)” because it is reversible, and it can be improved by the oral intake of bioactives17-18.
The mixture of amino acids was chosen based on the results of a previous in vitro study aimed to demonstrate, in cultured human fibroblasts, to clarify whether the amino acids mixture could produce both collagen and elastin and to optimize the rations between the amino acids in the mixture19. These results were further confirmed by another in vitro study, in which the authors demonstrated an upregulation of elastin, fibronectin, and collagen 1 gene expression in cultured human fibroblasts20. This study was aimed at investigating the clinical efficacy of the amino acid’s mixture on skin. Further endpoints included the analysis of hair and nails parameters.
Materials and Methods
Study design, subjects, and locations
This monocentric, open label study included twenty-one (N = 21) healthy Caucasian female screened and enrolled by a dermatologist. The study was conducted according to the study protocol approved by the “Independent Ethical Committee for Non-Pharmacological Clinical trials” (ref. 2021/14) under the Declaration of Helsinki principles. Both the informed consent form and the written permission for the picture use, were obtained before the subject enrolment in the study. This study included all the adult (35 ≤ age ≤ 70 years old) Caucasian female subjects showing the clinical signs of mild-to-moderate aging all over the face (including wrinkles/fine lines, loss of skin firmness/elasticity, and normal to dry skin), acute telogen effluvium, and brittle/fragile nails. The study further included subjects of good general health, with a dermatological anamnesis free of any active skin, nails, and hair diseases (e.g. atopic dermatitis, skin elastosis, etc.). The study excluded pregnant or breastfeeding women, subjects planning a pregnancy, and dermatological diseases or altered conditions in the test area including sensitive or hyper-reactive skin. Avoiding artificial or natural UV exposure was a constraint during all the study period. Clinic visits were planned at baseline and after 28 (D28) and 84 (84) days of product intake.
The study was conducted by Complife Italia Srl (San Martino Siccomario, Pavia, Italy) from October 2021 to April 2022. Complife Italia is an independent testing laboratory specialized in the in vitro and in vivo safety and efficacy testing of cosmetics, food supplements and medical devices.
Tested product
The tested product was a food supplement (Nutrakos Drinkable, Professional Dietetics S.p.A., Milano, Italy) containing Purified Water, Glycine, L-Alanine, L-Proline, L-Valine, L-Leucine, L-Lysine, Trisodium Citrate (E331), Acidifier: Citric Acid (E330), Preservative: Sodium Benzoate. The way and the frequency of use was as follows: during the first two weeks subjects took two stick packs per day, while from week 2 to week 12 subjects continued with 1 stick pack per day.
Subjects were also supplied with a base cream to standardize the cosmetic habits. The base cream ingredient list was as follows: Aqua, Helianthus Annuus Seed Oil, Isononyl Isononanoate, Polyglyceryl-3 Methylglucose Distearate, Glyceryl Stearate, Cetearyl Alcohol, Disodium EDTA, Chlorphenesin, O-Cymen-5-Ol, Fragrance/Parfum.
Primary and secondary endpoints/outcomes
The evaluation of wrinkle depth, hair shedding and nail conditions was the primary efficacy endpoint. The primary outcomes were the measurement of the wrinkle depth, the percentage of telogen hair and the clinical evaluation of nail status.
The secondary outcomes of the study included the evaluation of the skin roughness, moisturization, elasticity and thickness. These endpoints were measured by instruments but also assessed by dermatologist clinical scoring and/or by the subject’s perception.
The measurement process was carried out under temperature (21± 1°C) and humidity (50 ± 10%) controlled conditions after a 15/20 minutes acclimatation period.
Skin profilometry
Wrinkle depth and skin roughness (Sa parameter) were measured by a 3D imaging device (PRIMOSCR, Canfield Scientific, Utrecht, Netherlands). The measurement principle of the device is based on the 3D fringe projection technology. The before/after pictures overlapping and matching were regulated electronically by a specific feature of the device integrated software and physically by a stereotactic device (Canfield Scientific, Utrecht, Netherlands). Both the wrinkle depth and the skin roughness were measured in the periocular area (‘crow’s feet wrinkles’). Sa is inversely related to skin smoothness.
Superficial and deep skin moisturization
The superficial moisturization of the skin (measurement depth: 10-20 µm) was measured by a Corneometer® CM 825 (Courage + Khazaka, electronic GmbH, Cologne, Germany).
The deep (500 µm) skin moisturization was measured by a MoistureMeterD (Delfin Technologies Ltd, Bergamo, Italy) method.
Skin elasticity
The skin elasticity was measured in the cheek area by a Cutometer® MPA 580 (Courage + Khazaka, electronic GmbH, Cologne, Germany). The R0 (skin distensibility) and R2 (overall elasticity) parameters were measured.
Skin thickness
Skin thickness was measured by an Aloka a6 pro-sound (Hitachi) ultrasound machine. The ultrasound machine allows to measure the skin thickness (epidermidis + dermis). In the analyzed region, skin thickness was measured in five points (white dotted lines).
Phototricogram
Phototricogram was performed according to the TrichoScan® supplier recommendations, as follows: i) hair clipping and trimming; ii) removal of the trimmed hair with a sticky tape; iii) hair dyeing; iv) removal of dye remnants using a swab and an alcoholic solution; v) picture taking 48 hours after clipping. Anagen/telogen hair, the total hair number, and hair density were calculated by TrichoScan® software.
Clinical analysis
Skin, hair, and nails parameters were assessed by the dermatologist by a clinical scoring system, as follows:
Skin wrinkledness at baseline was scored according to the modified Fitzpatrick wrinkle scale21,22; while at the follow-up visits it was scored according to an improvement scale*.
Skin firmness: 1 Not firm skin (Inelastic, thinned, not dense and relaxed skin with bad resistance to pinching/pulling and a poor elastic recovery after traction), 2 Not very firm skin (Poorly elastic, thinned and less dense skin, initial tissue relaxation with poor resistance to pinching/pulling and a poor elastic recovery after traction) 3 Sufficient firm skin (medium tone, sufficiently full, plump and dense skin, tissues appear slightly relaxed with sufficient resistance to pinching/pulling and a quite good elastic recovery after traction), 4 Firm skin (full and plump skin, tissues don’t appear relaxed with good resistance to pinching/pulling and a good elastic recovery after traction, 5 Very firm skin (full and plump skin, tissues are not relaxed with an excellent resistance to pinching/pulling and an excellent elastic recovery after traction).
Nail status was scored at baseline according to the clinical scoring system reported here below; while at the follow-up visits it was scored according to an improvement scale*:
Nails hardness: 1 Nails appear brittle, weak, not very resistant and with a tendency to break, 2 Nails appear slightly brittle, weak, with a slight tendency to break, 3 Nails appear compact, hard, and durable.
Nails hydration: 1 Nails appear dry, flaked, brittle with a tendency to break, 2 Nails appear slightly flaked, brittle with a slight tendency to break, 3 Nails appear hydrated, hard, and resistant.
Nails smoothness: 1 Nails appear rough, unpolished, and uneven, 2 Nails appear smooth and not very uniform, 3 Nails appear smooth and uniform.
Nails plate evenness: 1 Nails appear rough and/or with uneven pigmentation with uneven and uneven surface (striped/wavy), 2 Nails appear slightly rough with uneven and uneven surface (striped/wavy), 3 Nails appear smooth/even, regular, and homogeneous.
* 1 No variation, 2 Slight improvement, 3 Moderate improvement, 4 Remarkable improvement.
Self-assessment questionnaire
At D84 subjects compiled a self-assessment questionnaire. The self-assessment questionnaire items investigated the product performance on skin, hair, and nails.
Statistical analysis
Statistical analysis was carried out by a statistician using NCSS 8 (NCSS, Kaysville, UT, USA). Symmetrically distributed normal data (instrumental measurements) were analyzed by a two-way t test of Student; while non-parametric data (clinical analysis) were analyzed by Wilcoxon test. A p values less than 0.05 was considered statistically significant. Statistical analysis output was reported as follows: *p < 0.05, **p < 0.01, and ***p < 0.001.
Results
Subjects and product tolerability
A total of twenty-two (N = 22) female subjects were enrolled in the study. Subjects attended clinic visits at baseline (D0) and after 28 days (D28) and 84 days (D84) of product intake. One subject dropped out for personal reasons (not dependent by the product use). The subjects’ baseline demographics are detailed in Table 1. The product was well tolerated. No adverse reactions, neither objective nor subjective, were reported by the dermatologist or by the subject, respectively.
Table 1: Demographic and clinical characteristics of the study participants at baseline.
Baseline characteristic |
Value |
Units |
Sex |
||
Female |
21 (100%) |
N (%) |
Age |
53.6 ± 1.5 |
Years |
Skin type |
||
Normal |
9 (47.6%) |
N (%) |
Combination |
11 (52.4%) |
N (%) |
Skin moisturization |
||
Superficial |
49.7 ± 1.5 |
Corneometric units |
Deep |
40.7 ± 1.1 |
% of water |
Skin elasticity |
||
R0 (skin distensibility) |
0.450 ± 0.013 |
mm |
R2 (overall elasticity) |
0.607 ± 0.016 |
% |
Wrinkle depth |
263.0 ± 20.0 |
mm |
Skin smoothness (Sa) |
46.02 ± 1.77 |
mm |
Skin thickness |
1.38 ± 0.04 |
mm |
Pull test |
12.8 ± 0.6 |
Hair no. |
Phototricogram |
||
Hair density |
182.1 ± 6.8 |
Hair no. |
Anagen hair density |
128.6 ± 5.3 (70.6%) |
Hair no. (%) |
Telogen hair density |
53.5 ± 2.9 (29.4%) |
Hair no. (%) |
Primary endpoints: wrinkle depth, hair loss, nail status
The primary endpoints related to the product performances on skin, hair, and nail conditions were measured by means of image analysis on 3D pictures, by phototricogram, and by clinical analysis, respectively. Data are reported in Fig. 1-3.
The “crow’s feet” wrinkle depth was significantly lower (p<0.001) after both 28 (-9.5%) and 84 (-14.5%) days of product intake (Fig. 1a). The decrease of the wrinkle depth was seen also by the dermatologist in most of the subject (62% at D28 and 76% at D84). A similar trend was observed also for the skin smoothness (Sa) parameter. Sa parameter (Fig. 1b) was significantly (p<0.001) reduced after both 28 (-4.9%) and 84 (-7.7%) days of product intake (Fig. 1b).
Figure 1: (a) Wrinkle depth. (b) Skin smoothness. Data are average (± standard error). |
The phototricogram analysis (Fig. 2) showed an improvement of the hair density (both total and anagen/telogen density). In particular, the telogen hair percentage, after 84 days of product intake, was decreased by -9.5% (p<0.001).
Figure 2: Phototricogram results. (a) Total hair density. (b) Anagen hair %. (c) Telogen hair %. Data are average (± standard error). |
Nail conditions (Fig. 3) were improved (from mild to moderate improvement) both after 84 days of product intake. The responder to treatment were as follows: 62% of subjects for nails hardness, smoothness and evenness, and b) 67% for nails hydration.
Figure 3: Nails conditions after 84 days of intake. Data are the percentage of subjects showing an improvement (responders). |
Secondary endpoints
The secondary endpoints as related to the product efficacy are reported in table 2.
Table 2: Secondary endpoints results. Data are average (± standard error). In bracket is reported the variation (difference or percentage). The statistical analysis is reported as follows: * p<0.05, ** p<0.01, and *** p<0.001. D0 baseline. D28/84 follow-up visit after 28/84 days of product intake. cu corneometric units
Parameter |
D0 |
D28 |
D84 |
Units |
Skin moisturization |
|
|
|
|
Superficial (≈ 20 mm) |
49.7±1.5 |
52.6±1.4*** (+6.0%) |
54.3±1.4*** (+9.2%) |
cu |
Deep (≈ 500 mm) |
40.7±1.1 |
42.3±1.0*** (+4.2%) |
43.7±1.0*** (+7.6%) |
% water |
Skin elasticity |
|
|
|
|
R0 parameter |
0.450±0.013 |
0.396±0.010*** (-11.5%) |
0.362±0.012*** (-19.3%) |
mm |
R2 parameter |
0.607±0.016 |
0.652±0.017*** (+7.8%) |
0.677±0.017*** (+11.9%) |
% |
Skin thickness |
1.38±0.04 |
1.49±0.03*** (+0.11) |
1.62±0.04*** (+0.24) |
mm |
The superficial (≈ 20 mm) skin moisturization (Table 3) was increased (p<0.001) by 6.0% and 9.2% after 28 and 84 days of product intake, respectively. Similar results were obtained for the deep (≈ 500 mm) moisturization. The deep skin moisturization was increased (p<0.001) by 4.2% and 7.6% after 28 and 84 days of product intake, respectively.
The skin distensibility (R0, skin firmness) was decreased (p<0.001) by 11.5% and 19.3% after 28 and 84 days of product intake. An improvement of skin firmness was seen also by the dermatologist in most of the subject (62% at D28 and 76% at D84).
The skin overall elasticity (R2) was increased (p<0.001) by 7.8% and 11.9% after 28 and 84 days of product intake. The R2 parameter increase is related to an improvement of the function of the elastic fibers of the skin.
The skin thickness was significantly increased (p<0.001) starting from 28 days of product intake with a mean increase by 0.11 mm. The skin thickness was further increased (p<0.001) by 0.24 mm after 84 days of product intake.
Starting from the 28th day of product intake the pull test was not indicative for telogen effluvium. The total number of hair plucked was 9.9 at D28 (p<0.001) and 6.3 at D84 (p<0.001).
Self-assessment questionnaire
The product was scored positively by most of the subjects participating in the study (Table 3). The product efficacy was seen by most of the subjects, as follows: between 1 and 2 months of product intake for skin effects (after 1 months by 42.9% of subjects, after 2 months by 52.4% of subjects, and after 3 months by 4.8% of subjects), between 1 and 2 months of product intake for hair effects (after 1 months by 38.1% of subjects, after 2 months by 38.1% of subjects, after 3 months by 14.3% of subjects, and never by 9.5% of subjects), and between 1 and 2 months of product intake for nails effects (after 1 months by 19.0% of subjects, after 2 months by 52.4% of subjects, after 3 months by 19.0% of subjects, and never by 9.5% of subjects).
Table 3: Self-assessment questionnaire output. Data are the percentage of subjects giving a particular answer.
No. |
Item |
Comple-tely agree (%) |
Agree
(%) |
Disagree
(%) |
Completely disagree (%) |
Positive answers (%) |
Skin |
|
|
|
|
|
|
01 |
The product improves the overall appearance of my skin |
28.6 |
66.7 |
4.8 |
0.0 |
95.2 |
02 |
My skin looks more radiant |
23.8 |
61.9 |
9.5 |
4.8 |
85.7 |
03 |
I fell my skin smoother |
23.8 |
61.9 |
14.3 |
0.0 |
85.7 |
04 |
The appearance of mi fine lines and wrinkles is reduced |
23.8 |
47.6 |
23.8 |
4.8 |
71.4 |
05 |
I feel my skin more hydrated |
28.6 |
61.9 |
9.5 |
0.0 |
90.5 |
Hair |
|
|
|
|
|
|
06 |
The product improves the overall appearance of my hair |
52.4 |
33.3 |
4.8 |
9.5 |
85.7 |
07 |
My hair is strengthened |
42.9 |
47.6 |
9.5 |
0.0 |
90.5 |
08 |
My hair is stronger and more vigorous |
38.1 |
38.1 |
23.8 |
0.0 |
76.2 |
09 |
The product makes the hair thicker |
42.9 |
33.3 |
14.3 |
9.5 |
76.2 |
10 |
The product visibly reduces hair loss |
33.3 |
57.1 |
9.5 |
0.0 |
90.5 |
11 |
The product maintains the health of the hair: |
42.9 |
42.9 |
14.3 |
0.0 |
85.7 |
12 |
I feel the hair less brittle, sparse and thin: |
38.1 |
47.6 |
14.3 |
0.0 |
85.7 |
Nails |
|
|
|
|
|
|
13 |
The product improves the overall appearance of my nails |
19.0 |
52.4 |
19.0 |
9.5 |
71.4 |
14 |
My nails are strengthened |
14.3 |
52.4 |
33.3 |
0.0 |
66.7 |
15 |
My nails are stronger |
14.3 |
52.4 |
33.3 |
0.0 |
66.7 |
16 |
My nails are more durable |
14.3 |
52.4 |
33.3 |
0.0 |
66.7 |
17 |
My nails are less brittle |
14.3 |
57.1 |
28.6 |
0.0 |
71.4 |
18 |
My nails are less weak |
14.3 |
57.1 |
28.6 |
0.0 |
71.4 |
19 |
The surface of my nails is smoother |
14.3 |
52.4 |
33.3 |
0.0 |
66.7 |
20 |
The product maintains the health of the nails |
19.0 |
52.4 |
28.6 |
0.0 |
71.4 |
Overall satisfaction |
|
|
|
|
|
|
21 |
Overall, how satisfied are you with the product for its effect on your skin? |
28.6 |
66.7 |
4.8 |
0.0 |
95.2 |
22 |
Overall, how satisfied are you with the product for its effect on your hair? |
52.4 |
33.3 |
4.8 |
9.5 |
85.7 |
23 |
Overall, how satisfied are you with the product for its effect on your nails? |
19.0 |
52.4 |
19.0 |
9.5 |
71.4 |
|
|
Yes |
No |
|
|
|
24 |
Did you like the taste of the product? |
90.5 |
9.5 |
|
|
|
25 |
Is the product well tolerated? |
100.0 |
0.0 |
|
|
|
26 |
Would you buy the product? |
85.7 |
14.3 |
|
|
|
Discussion
The skin, hair and nail health is undermined by different conditions that have a direct impact on subjects’ self-esteem and social interactions4,15,23,24. Different aesthetic treatments/procedures and or pharmacological approaches are available to improve skin, hair, and nail appearance, however, subjects can be reluctant to them, due to invasiveness, side effects and cost.
In this study we assessed the efficacy of a food supplement containing amino acids (Glycine, L-Alanine, L-Proline, L-Valine, L-Leucine, L-Lysine) in improving the skin appearance (antiaging effect), in reducing the hair loss in subjects with aTE, and in improving the nail plate conditions in subjects with BNS.
The product showed to be effective in improving a) the aesthetical appearance of the skin (skin wrinkledness) and its conditions (moisturization and thickness), b) in reducing the hair loss in subjects with aTE, and c) in improving the nail status and conditions. Interestingly, the instrumentally measured improvement of the measured parameters was also visible to the clinical analysis carried out by the dermatologist and perceived by the subjects.
Limitations. The study design was open label while a randomized clinical trial would be the golden standard study design. However, the study design was not influencing data analysis since the study staff was blind to treatment and to Sponsor. Future research may consider greater focus on enhanced the study design (e.g. a randomized clinical trial design).
The intake of Nutrakos Drinkable (Professional Dietetics S.p.A., Milano, Italy) for 84 days was effective in improving the skin appearance (antiaging effect), in reducing hair loss (in subjects with aTE), and in improving nail appearance (in subjects with BNS). The product intake was well-tolerated. To the best of our knowledge, this is the first study reporting the efficacy of a food supplement containing amino acids (Glycine, L-Alanine, L-Proline, L-Valine, L-Leucine, L-Lysine) in improving skin, hair, and nails appearance.
Acknowledgment
The authors would like to express their gratitude to the Complife staff, who contributed to the study and recruited the subjects, for their professionalism and support during the study development.
Funding source
The study was funded by Professional Dietetics S.p.A., Milano, Italy.
Conflict of interest
The author declares no conflicts of interest.
Authors’ Contribution
Each author mentioned has significantly and directly contributed intellectually to the project and has given its approval for its publication.
Data Availability Statement
The data presented in this study are available on request from the corresponding author. The data are not publicly available since they are the property of the sponsor of the study (Professional Dietetics S.p.A., Milano, Italy).
Ethics Statement
The study protocol and the informed consent form were approved by the “Independent Ethical Committee for Non-Pharmacological Clinical trials” (ref. 2021/14).
Informed Consent Statement
Written informed consent has been obtained from the patient(s) to publish this paper.
References
- Katta R, Huang S. Skin, Hair and Nail Supplements: An Evidence-Based Approach. Skin Therapy Lett. 2019 Sep;24(5):7-13. PMID: 31584785.
- Jhawar N, Wang JV, Saedi N. Oral collagen supplementation for skin aging: A fad or the future? J Cosmet Dermatol. 2020 Apr;19(4):910-912. doi: 10.1111/jocd.13096. Epub 2019 Aug 14. PMID: 31411379.
CrossRef - Dini I, Laneri S. Nutricosmetics: A brief overview. Phytother Res. 2019 Dec;33(12):3054-3063. doi: 10.1002/ptr.6494. Epub 2019 Sep 3. PMID: 31478301.
CrossRef - Vettorazzi A, López de Cerain A, Sanz-Serrano J, Gil AG, Azqueta A. European Regulatory Framework and Safety Assessment of Food-Related Bioactive Compounds. Nutrients. 2020 Feb 26;12(3):613. doi: 10.3390/nu12030613. PMID: 32110982; PMCID: PMC7146632.
CrossRef - Nobile V, Tursi F, Cestone E, Sergheraert R, Duperray J. The effects of the oral supplementation with a natural keratin hydrolysate (Kera-Diet®) on hair and nails: Randomized, placebo and benchmark-controlled clinical trial on healthy females. Trichol Cosmetol Open J. 2021; 4(1): 7-16. doi: 10.17140/TCOJ-4-115
CrossRef - MacKay D, Miller AL. Nutritional support for wound healing. Altern Med Rev. 2003 Nov;8(4):359-77. PMID: 14653765.
- Danby FW. Nutrition and aging skin: sugar and glycation. Clin Dermatol. 2010 Jul-Aug;28(4):409-11. doi: 10.1016/j.clindermatol.2010.03.018. PMID: 20620757.
CrossRef - Melnik BC. Linking diet to acne metabolomics, inflammation, and comedogenesis: an update. Clin Cosmet Investig Dermatol. 2015 Jul 15;8:371-88. doi: 10.2147/CCID.S69135. PMID: 26203267; PMCID: PMC4507494.
CrossRef - Cao C, Xiao Z, Wu Y, Ge C. Diet and Skin Aging-From the Perspective of Food Nutrition. Nutrients. 2020 Mar 24;12(3):870. doi: 10.3390/nu12030870. PMID: 32213934; PMCID: PMC7146365.
CrossRef - Solano F. Metabolism and Functions of Amino Acids in the Skin. Adv Exp Med Biol. 2020;1265:187-199. doi: 10.1007/978-3-030-45328-2_11. PMID: 32761577.
CrossRef - Li P, Wu G. Roles of dietary glycine, proline, and hydroxyproline in collagen synthesis and animal growth. Amino Acids. 2018 Jan;50(1):29-38. doi: 10.1007/s00726-017-2490-6. Epub 2017 Sep 20. PMID: 28929384.
CrossRef - Karna E, Szoka L, Huynh TYL, Palka JA. Proline-dependent regulation of collagen metabolism. Cell Mol Life Sci. 2020 May;77(10):1911-1918. doi: 10.1007/s00018-019-03363-3. Epub 2019 Nov 18. PMID: 31740988; PMCID: PMC7228914.
CrossRef - Asghar F, Shamim N, Farooque U, Sheikh H, Aqeel R. Telogen effluvium: A review of the literature. Cureus. 2020; 12(5): e8320. doi: 10.7759/cureus.8320
CrossRef - Asghar F, Shamim N, Farooque U, Sheikh H, Aqeel R. Telogen Effluvium: A Review of the Literature. Cureus. 2020 May 27;12(5):e8320. doi: 10.7759/cureus.8320. PMID: 32607303; PMCID: PMC7320655.
CrossRef - Trüeb RM. Systematic approach to hair loss in women. J Dtsch Dermatol Ges. 2010 Apr;8(4):284-97, 284-98. English, German. doi: 10.1111/j.1610-0387.2010.07261.x. Epub 2010 Jan 22. PMID: 20105246.
CrossRef - Double-blind data confirmed the findings of an open study in women with increased hair shedding, where a significant proportion responded to l-lysine and iron therapy.
CrossRef - Chessa MA, Iorizzo M, Richert B, López-Estebaranz JL, Rigopoulos D, Tosti A, Gupta AK, Di Chiacchio N, Di Chiacchio NG, Rubin AI, Baran R, Lipner SR, Daniel R, Chiheb S, Grover C, Starace M, Piraccini BM. Pathogenesis, Clinical Signs and Treatment Recommendations in Brittle Nails: A Review. Dermatol Ther (Heidelb). 2020 Feb;10(1):15-27. doi: 10.1007/s13555-019-00338-x. Epub 2019 Nov 20. Erratum in: Dermatol Ther (Heidelb). 2020 Jan 22;: PMID: 31749091; PMCID: PMC6994568.
CrossRef - Hexsel D, Zague V, Schunck M, Siega C, Camozzato FO, Oesser S. Oral supplementation with specific bioactive collagen peptides improves nail growth and reduces symptoms of brittle nails. J Cosmet Dermatol. 2017 Dec;16(4):520-526. doi: 10.1111/jocd.12393. Epub 2017 Aug 8. PMID: 28786550.
CrossRef - De Servi B, Orlandini A, Caviola E, Meloni M. Amino acid and hyaluronic acid mixtures differentially regulate extra cellular matrix genes in cultured human fibroblasts. J Biol Regul Homeost Agents. 2018;32(3):517-527.
- Tedesco L, Rossi F, Ruocco C, et al. A designer mixture of six amino acids promotes the extracellular matrix gene expression in cultured human fibroblasts. Biosci Biotechnol Biochem. 2022;86(9):1255-1261. doi:10.1093/bbb/zbac101
CrossRef - Shoshani D, Markovitz E, Monstrey SJ, Narins DJ. The modified Fitzpatrick Wrinkle Scale: a clinical validated measurement tool for nasolabial wrinkle severity assessment. Dermatol Surg. 2008;34 Suppl 1:S85-S91. doi:10.1111/j.1524-4725.2008.34248.x
CrossRef - Nobile V, Spartà E, Zanoletti V, Sandolo F, Cestone E. Efficacy Evaluation of a Cosmetic Product for the Periocular Area in Caucasian Women Aged Over 40 Years Old. Clin Cosmet Investig Dermatol. 2022;15:2933-2941. Published 2022 Dec 29. doi:10.2147/CCID.S377930
CrossRef - Demir B, Cicek D, Orhan C, Er B, Erten F, Tuzcu M, Ozercan IH, Sahin N, Komorowski J, Ojalvo SP, Sylla S, Sahin K. Effects of a Combination of Arginine Silicate Inositol Complex and a Novel Form of Biotin on Hair and Nail Growth in a Rodent Model. Biol Trace Elem Res. 2022 Feb 28:1–15. doi: 10.1007/s12011-022-03176-9. Epub ahead of print. PMID: 35226275; PMCID: PMC8883010.
- Belyayeva E, Gregoriou S, Chalikias J, Kontochristopoulos G, Koumantaki E, Makris M, Koti I, Katoulis A, Katsambas A, Rigopoulos D. The impact of nail disorders on quality of life. Eur J Dermatol. 2013 May-Jun;23(3):366-71. doi: 10.1684/ejd.2013.2048. PMID: 23816658.
CrossRef
This work is licensed under a Creative Commons Attribution 4.0 International License.